283 related articles for article (PubMed ID: 34535993)
41. COVID-19, hypertension, and renin-angiotensin-aldosterone system inhibitors: Much ado about nothing or real problem to be solved?
Tadic M; Cuspidi C
J Clin Hypertens (Greenwich); 2020 Nov; 22(11):1984-1986. PubMed ID: 32951351
[No Abstract] [Full Text] [Related]
42. Covid-19: the renin-angiotensin system imbalance hypothesis.
Lanza K; Perez LG; Costa LB; Cordeiro TM; Palmeira VA; Ribeiro VT; Simões E Silva AC
Clin Sci (Lond); 2020 Jun; 134(11):1259-1264. PubMed ID: 32507883
[TBL] [Abstract][Full Text] [Related]
43. SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients.
Quarleri J; Delpino MV
Geroscience; 2022 Apr; 44(2):547-565. PubMed ID: 35157210
[TBL] [Abstract][Full Text] [Related]
44. [Renin-angiotensin-aldosterone system : brief history and questions related to the COVID-19 pandemic].
Valdes-Socin H; Jouret F; Vroonen L; Scheen AJ; Lancellotti P
Rev Med Liege; 2020 Sup; 75(S1):123-129. PubMed ID: 33211434
[TBL] [Abstract][Full Text] [Related]
45. RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one.
Rothlin RP; Pelorosso F; Duarte M; Nicolosi L; Fernandez Criado I; Salgado MV; Vetulli H
Rev Port Cardiol; 2024 Apr; 43(4):219-220. PubMed ID: 37940073
[No Abstract] [Full Text] [Related]
46. Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one.
Gonçalves J; Santos CD; Fresco P; Fernandez-Llimos F
Rev Port Cardiol; 2024 Apr; 43(4):221-222. PubMed ID: 37918782
[No Abstract] [Full Text] [Related]
47. Reply to Akin
Leisman DE; Mehta A; Thompson BT; Hacohen N; Filbin MR; Goldberg MB
Am J Respir Crit Care Med; 2022 May; 205(10):1253-1254. PubMed ID: 35348420
[No Abstract] [Full Text] [Related]
48. Reply to Tedeschi et al.
Hanff TC; Harhay MO; Brown TS; Cohen JB; Mohareb AM
Clin Infect Dis; 2020 Jul; 71(15):901. PubMed ID: 32339227
[No Abstract] [Full Text] [Related]
49. Efficacy and safety of ivermectin for the treatment of COVID-19: a systematic review and meta-analysis.
Deng J; Zhou F; Ali S; Heybati K; Hou W; Huang E; Wong CY
QJM; 2021 Dec; 114(10):721-732. PubMed ID: 34570241
[TBL] [Abstract][Full Text] [Related]
50. Improved COVID-19 Outcomes following Statin Therapy: An Updated Systematic Review and Meta-analysis.
Vahedian-Azimi A; Mohammadi SM; Banach M; Beni FH; Guest PC; Al-Rasadi K; Jamialahmadi T; Sahebkar A
Biomed Res Int; 2021; 2021():1901772. PubMed ID: 34568488
[TBL] [Abstract][Full Text] [Related]
51. Testosterone, free, bioavailable and total, in patients with COVID-19.
Ilias I; Pratikaki M; Diamantopoulos A; Jahaj E; Mourelatos P; Athanasiou N; Tsipilis S; Zacharis A; Vassiliou AG; Vassiliadi DA; Tsagarakis S; Kotanidou A; Dimopoulou I
Minerva Endocrinol (Torino); 2022 Mar; 47(1):111-116. PubMed ID: 34546019
[TBL] [Abstract][Full Text] [Related]
52. SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study.
Stirrup O; Boshier F; Venturini C; Guerra-Assunção JA; Alcolea-Medina A; Beckett A; Charalampous T; da Silva Filipe A; Glaysher S; Khan T; Kulasegaran Shylini R; Kele B; Monahan I; Mollett G; Parker M; Pelosi E; Randell P; Roy S; Taylor J; Weller S; Wilson-Davies E; Wade P; Williams R; ; ; Copas A; Cutino-Moguel MT; Freemantle N; Hayward AC; Holmes A; Hughes J; Mahungu T; Nebbia G; Partridge D; Pope C; Price J; Robson S; Saeed K; de Silva T; Snell L; Thomson E; Witney AA; Breuer J
BMJ Open Respir Res; 2021 Sep; 8(1):. PubMed ID: 34544733
[TBL] [Abstract][Full Text] [Related]
53. Hypophosphatemia is an independent risk factor for AKI among hospitalized patients with COVID-19 infection.
Chen Z; Gao C; Yu H; Lu L; Liu J; Chen W; Xiang X; Hussain HMJ; Lee BJ; Li C; Wei W; Huang Y; Li X; Fang Z; Yu S; Weng Q; Ouyang Y; Hu X; Tong J; Liu J; Lin L; Liu M; Xu X; Liu D; Song Y; Lv X; Zha Y; Ye Z; Jiang T; Jia J; Chen X; Bi Y; Xue J; Chen N; Hu W; He CJ; Wang H; Liu J; Xie J
Ren Fail; 2021 Dec; 43(1):1329-1337. PubMed ID: 34541999
[TBL] [Abstract][Full Text] [Related]
54. Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile.
Bueno SM; Abarca K; González PA; Gálvez NMS; Soto JA; Duarte LF; Schultz BM; Pacheco GA; González LA; Vázquez Y; Ríos M; Melo-González F; Rivera-Pérez D; Iturriaga C; Urzúa M; Domínguez A; Andrade CA; Berríos-Rojas RV; Canedo-Marroquín G; Covián C; Moreno-Tapia D; Saavedra F; Vallejos OP; Donato P; Espinoza P; Fuentes D; González M; Guzmán P; Muñoz Venturelli P; Pérez CM; Potin M; Rojas Á; Fasce RA; Fernández J; Mora J; Ramírez E; Gaete-Argel A; Oyarzún-Arrau A; Valiente-Echeverría F; Soto-Rifo R; Weiskopf D; Sette A; Zeng G; Meng W; González-Aramundiz JV; Kalergis AM
Clin Infect Dis; 2022 Aug; 75(1):e792-e804. PubMed ID: 34537835
[TBL] [Abstract][Full Text] [Related]
55. Influence of renin-angiotensin-aldosterone system inhibitors on plasma levels of angiotensin-converting enzyme 2.
Zimmermann T; Walter JE; Lopez-Ayala P; Strebel I; Amrein M; Koechlin M; Honegger U; Mueller C;
ESC Heart Fail; 2021 Apr; 8(2):1717-1721. PubMed ID: 34596976
[TBL] [Abstract][Full Text] [Related]
56. SARS-CoV-2 Delta variant infects ACE2
Li H; Liu T; Wang L; Wang M; Wang S
J Med Virol; 2022 Mar; 94(3):821-822. PubMed ID: 34596249
[No Abstract] [Full Text] [Related]
57. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later.
Angeli F; Zappa M; Reboldi G; Trapasso M; Cavallini C; Spanevello A; Verdecchia P
Eur J Intern Med; 2021 Nov; 93():28-34. PubMed ID: 34588140
[No Abstract] [Full Text] [Related]
58. A prenylated dsRNA sensor protects against severe COVID-19.
Wickenhagen A; Sugrue E; Lytras S; Kuchi S; Noerenberg M; Turnbull ML; Loney C; Herder V; Allan J; Jarmson I; Cameron-Ruiz N; Varjak M; Pinto RM; Lee JY; Iselin L; Palmalux N; Stewart DG; Swingler S; Greenwood EJD; Crozier TWM; Gu Q; Davies EL; Clohisey S; Wang B; Trindade Maranhão Costa F; Freire Santana M; de Lima Ferreira LC; Murphy L; Fawkes A; Meynert A; Grimes G; ; Da Silva Filho JL; Marti M; Hughes J; Stanton RJ; Wang ECY; Ho A; Davis I; Jarrett RF; Castello A; Robertson DL; Semple MG; Openshaw PJM; Palmarini M; Lehner PJ; Baillie JK; Rihn SJ; Wilson SJ
Science; 2021 Oct; 374(6567):eabj3624. PubMed ID: 34581622
[TBL] [Abstract][Full Text] [Related]
59. Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication.
Chu J; Xing C; Du Y; Duan T; Liu S; Zhang P; Cheng C; Henley J; Liu X; Qian C; Yin B; Wang HY; Wang RF
Nat Metab; 2021 Nov; 3(11):1466-1475. PubMed ID: 34580494
[TBL] [Abstract][Full Text] [Related]
60. An international comparison of age and sex dependency of COVID-19 deaths in 2020: a descriptive analysis.
Bauer P; Brugger J; König F; Posch M
Sci Rep; 2021 Sep; 11(1):19143. PubMed ID: 34580322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
